Discovery and characterization of berberine derivatives as stimulators of osteoblast differentiation

키워드

참고문헌 (36)

1. Leon Snyman, "Menopause-related osteoporosis", South African Family Practice, 56(3), pp.174~177 (2014), AOSIS[DOI]
2. Kristine E. Ensrud, "Osteoporosis", Annals of Internal Medicine, 167(3), pp.ITC17~ITC32 (2017), American College of Physicians[DOI]
3. Salvatore L. Ruggiero, "American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update", Journal of Oral and Maxillofacial Surgery, 72(10), pp.1938~1956 (2014), Elsevier BV[DOI]
4. Marius E. Kraenzlin, "Parathyroid hormone analogues in the treatment of osteoporosis", Nature Reviews Endocrinology, 7(11), pp.647~656 (2011), Springer Science and Business Media LLC[DOI]
5. Endo I, "Bone and Stem Cells. Regulatory mechanism of mesenchymal stem cell differentiation to osteoblasts", Clin Calcium, 24, pp.555~564 (2014)[DOI]
6. Shun-ichi Harada, "Control of osteoblast function and regulation of bone mass", Nature, 423(6937), pp.349~355 (2003), Springer Science and Business Media LLC[DOI]
7. Steven L. Teitelbaum, "Genetic regulation of osteoclast development and function", Nature Reviews Genetics, 4(8), pp.638~649 (2003), Springer Science and Business Media LLC[DOI]
8. Eric D. Jensen, "Regulation of gene expression in osteoblasts", BioFactors, 36, pp.25~32 (2010), Wiley[DOI]
9. Yan Li, "Biomechanical stimulation of osteoblast gene expression requires phosphorylation of the RUNX2 transcription factor", Journal of Bone and Mineral Research, 27(6), pp.1263~1274 (2012), Wiley[DOI]
10. D. Chen, "Bone Morphogenetic Protein 2 (BMP-2) Enhances BMP-3, BMP-4, and Bone Cell Differentiation Marker Gene Expression During the Induction of Mineralized Bone Matrix Formation in Culturesof Fetal Rat Calvarial Osteoblasts", Calcified Tissue International, 60(3), pp.283~290 (1997), Springer Science and Business Media LLC[DOI]
11. Fanxin Long, "Building strong bones: molecular regulation of the osteoblast lineage", Nature Reviews Molecular Cell Biology, 13(1), pp.27~38 (2012), Springer Science and Business Media LLC[DOI]
12. Jinkun Chen, "Developmental expression of bone sialoprotein mRNA in rat mineralized connective tissues", Journal of Bone and Mineral Research, 7(8), pp.987~997 (1992), Wiley[DOI]
13. Yifeng Jin, "Pharmacological effects of berberine and its derivatives: a patent update", Expert Opinion on Therapeutic Patents, 26(2), pp.229~243 (2015), Informa Healthcare[DOI]
14. P Wei, "Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells", Zhong Xi Yi Jie He Xue Bao, 7(4), pp.342~348 (2009), Journal of Chinese Integrative Medicine Press[DOI]
15. Huiying Li, "Effect of Berberine on Bone Mineral Density in SAMP6 as a Senile Osteoporosis Model", Biological & Pharmaceutical Bulletin, 26(1), pp.110~111 (2003), Pharmaceutical Society of Japan[DOI]
16. Sang-Yong Han, "Berberine Suppresses RANKL-Induced Osteoclast Differentiation by Inhibiting c-Fos and NFATc1 Expression", The American Journal of Chinese Medicine, 47(02), pp.439~455 (2019), World Scientific Pub Co Pte Lt[DOI]
17. Hyun Woo Lee, "Berberine Promotes Osteoblast Differentiation by Runx2 Activation With p38 MAPK", Journal of Bone and Mineral Research, 23(8), pp.1227~1237 (2008), Wiley[DOI]
18. Yifeng Jin, "Discovery of Isoquinolinoquinazolinones as a Novel Class of Potent PPARγ Antagonists with Anti-adipogenic Effects", Scientific Reports, 6(1), pp.34661~ (2016), Springer Science and Business Media LLC[DOI]
19. Shagaf H Bakour, "Latest evidence on using hormone replacement therapy in the menopause", The Obstetrician & Gynaecologist, 17(1), pp.20~28 (2015), Wiley[DOI]
20. C. E. Bowring, "National Osteoporosis Society's Position Statement on hormone replacement therapy in the prevention and treatment of osteoporosis", Menopause International, 17(2), pp.63~65 (2011), SAGE Publications[DOI]
21. Bruce Ettinger, "Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators", JAMA, 282(7), pp.637~645 (1999), American Medical Association (AMA)[DOI]
22. Cummings SR, "Prevention of breast cancer in postmenopausal women : approaches to estimating and reducing risk", J Natl Cancer Inst, 101, pp.384~398 (2009)[DOI]
23. Carolyn J. Crandall, "Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review", Annals of Internal Medicine, 161(10), pp.711~723 (2014), American College of Physicians[DOI]
24. Solomon CG, "Postmenopausal Osteoporosis", New England Journal of Medicine, 374(18), pp.1797~1797 (2016), Massachusetts Medical Society[DOI]
25. Mohammad Kharazmi, "Gender related difference in the risk of bisphosphonate associated atypical femoral fracture and osteonecrosis of the jaw", Annals of the Rheumatic Diseases, 73(8), pp.1594~1594 (2014), BMJ[DOI]
26. Danielle A Eekman, "Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice", BMC Musculoskeletal Disorders, 12(1), pp.167~ (2011), Springer Science and Business Media LLC[DOI]
27. E. Michael Lewiecki, "New and emerging concepts in the use of denosumab for the treatment of osteoporosis", Therapeutic Advances in Musculoskeletal Disease, 10(11), pp.209~223 (2018), SAGE Publications[DOI]
28. Jin-Ping Hu, "Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-κB and Akt pathways", European Journal of Pharmacology, 580(1-2), pp.70~79 (2008), Elsevier BV[DOI]
29. Zhou L, "Berberine sulfate attenuates osteoclast differentiation through RANKL induced NF-κB and NFAT pathways", Int J Mol Sci, 16, pp.27087~27096 (2015)[DOI]
30. T. Katagiri, "Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage", The Journal of Cell Biology, 127(6 Pt 1), pp.1755~1766 (1994), Rockefeller University Press[DOI]
31. Younho Han, "Berberine bioisostere Q8 compound stimulates osteoblast differentiation and function in vitro", Pharmacological Research, 119, pp.463~475 (2017), Elsevier BV[DOI]
32. Agnes D. Berendsen, "Osteoblast–adipocyte lineage plasticity in tissue development, maintenance and pathology", Cellular and Molecular Life Sciences, 71(3), pp.493~497 (2014), Springer Science and Business Media LLC[DOI]
33. Jin-Ran Chen, "Diet-Derived Phenolic Acids Regulate Osteoblast and Adipocyte Lineage Commitment and Differentiation in Young Mice", Journal of Bone and Mineral Research, 29(5), pp.1043~1053 (2014), Wiley[DOI]
34. Balasubramanian Arumugam, "Characterization of Runx2 phosphorylation sites required for TGF-β1-mediated stimulation of matrix metalloproteinase-13 expression in osteoblastic cells", Journal of Cellular Physiology, 233(2), pp.1082~1094 (2018), Wiley[DOI]
35. S. Vimalraj, "Runx2: Structure, function, and phosphorylation in osteoblast differentiation", International Journal of Biological Macromolecules, 78, pp.202~208 (2015), Elsevier BV[DOI]
36. T. Ogasawara, "Bone Morphogenetic Protein 2-Induced Osteoblast Differentiation Requires Smad-Mediated Down-Regulation of Cdk6", Molecular and Cellular Biology, 24(15), pp.6560~6568 (2004), American Society for Microbiology[DOI]

관련 논문AI추천